What does DR. VERCAUTEREN ROELAND do?

DR. VERCAUTEREN ROELAND is a specialist medical practice in Mortsel. Private Limited, started on 17 January 2011, 1 establishment.

What is the address of DR. VERCAUTEREN ROELAND?

The registered office of DR. VERCAUTEREN ROELAND is located at Floralaan 20, 2640 Mortsel.

Is DR. VERCAUTEREN ROELAND still active?

Yes. According to the CBE (17 September 2026) DR. VERCAUTEREN ROELAND is active, legal situation “Normale toestand”, started on 17 January 2011.

Is DR. VERCAUTEREN ROELAND registered on Peppol?

Yes, DR. VERCAUTEREN ROELAND is registered on the Peppol network with ID 0208:0833634232.

What is the enterprise number of DR. VERCAUTEREN ROELAND?

The enterprise number of DR. VERCAUTEREN ROELAND is BE0833634232.

When was DR. VERCAUTEREN ROELAND founded?

DR. VERCAUTEREN ROELAND was founded on 17 January 2011.

Who are the directors of DR. VERCAUTEREN ROELAND?

According to the 2025 annual accounts, the directors of DR. VERCAUTEREN ROELAND are: ROELAND VERCAUTEREN.

Is DR. VERCAUTEREN ROELAND a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 January 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. VERCAUTEREN ROELAND make in 2025?

DR. VERCAUTEREN ROELAND posted a profit after taxes of € 253,854 in financial year 2025.

What is the revenue of DR. VERCAUTEREN ROELAND?

As a small company, DR. VERCAUTEREN ROELAND is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 388,823.

DR. VERCAUTEREN ROELAND (Private Limited) - Mortsel

Dossier DR. VERCAUTEREN ROELAND, printed on 17 September 2026 from databakkes.be/en/0833634232/dr-vercauteren-roeland. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. VERCAUTEREN ROELAND from Mortsel, company number BE0833634232, closed financial year 2025 with a result of € 253,854 after tax. For that financial year DR. VERCAUTEREN ROELAND recorded a gross margin of € 388,823 and equity of € 703,881. Compared with financial year 2024, the result moved from € 192,119 to € 253,854. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.

What it is worth Healthy

€ 703,881

▼ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 253,854

▲ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 254,911

▼ 29% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 277,571 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 26,998

▼ 37% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 8,488

▲ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 73,650

▲ 166% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 174,815 Gross margin 2022: € 174,815 First fiscal year in the series	€ 199,585 Gross margin 2023: € 199,585 ▲ 14% vs 2022 (€ 174,815) Favourable step	€ 292,488 Gross margin 2024: € 292,488 ▲ 47% vs 2023 (€ 199,585) Favourable step	€ 388,823 Gross margin 2025: € 388,823 ▲ 33% vs 2024 (€ 292,488) Favourable step	▲ 33%
Profit after taxes	€ 115,235 Profit after taxes 2022: € 115,235 First fiscal year in the series	€ 128,414 Profit after taxes 2023: € 128,414 ▲ 11% vs 2022 (€ 115,235) Favourable step	€ 192,119 Profit after taxes 2024: € 192,119 ▲ 50% vs 2023 (€ 128,414) Favourable step	€ 253,854 Profit after taxes 2025: € 253,854 ▲ 32% vs 2024 (€ 192,119) Favourable step	▲ 32%
Equity	€ 529,784 Equity 2022: € 529,784 First fiscal year in the series	€ 608,369 Equity 2023: € 608,369 ▲ 15% vs 2022 (€ 529,784) Favourable step	€ 727,599 Equity 2024: € 727,599 ▲ 20% vs 2023 (€ 608,369) Favourable step	€ 703,881 Equity 2025: € 703,881 ▼ 3% vs 2024 (€ 727,599) Unfavourable step	▼ 3%
Total debts	€ 38,816 Total debts 2022: € 38,816 First fiscal year in the series	€ 56,539 Total debts 2023: € 56,539 ▲ 46% vs 2022 (€ 38,816) Unfavourable step	€ 36,737 Total debts 2024: € 36,737 ▼ 35% vs 2023 (€ 56,539) Favourable step	€ 94,231 Total debts 2025: € 94,231 ▲ 157% vs 2024 (€ 36,737) Unfavourable step	▲ 157%
Cash	€ 381,864 Cash 2022: € 381,864 First fiscal year in the series	€ 212,210 Cash 2023: € 212,210 ▼ 44% vs 2022 (€ 381,864) Unfavourable step	€ 360,223 Cash 2024: € 360,223 ▲ 70% vs 2023 (€ 212,210) Favourable step	€ 254,911 Cash 2025: € 254,911 ▼ 29% vs 2024 (€ 360,223) Unfavourable step	▼ 29%
Retained profit	€ 517,384 Retained profit 2022: € 517,384 First fiscal year in the series	€ 594,109 Retained profit 2023: € 594,109 ▲ 15% vs 2022 (€ 517,384) Favourable step	€ 713,339 Retained profit 2024: € 713,339 ▲ 20% vs 2023 (€ 594,109) Favourable step	€ 689,621 Retained profit 2025: € 689,621 ▼ 3% vs 2024 (€ 713,339) Unfavourable step	▼ 3%
Dividend	€ 58,239 Dividend 2022: € 58,239 First fiscal year in the series	€ 49,828 Dividend 2023: € 49,828 ▼ 14% vs 2022 (€ 58,239) Unchanged	€ 72,889 Dividend 2024: € 72,889 ▲ 46% vs 2023 (€ 49,828) Unchanged	€ 277,571 Dividend 2025: € 277,571 ▲ 281% vs 2024 (€ 72,889) Unchanged	▲ 281%
Bank debt	€ 526 Bank debt 2022: € 526 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 526) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 568,599 Balance sheet total 2022: € 568,599 First fiscal year in the series	€ 664,908 Balance sheet total 2023: € 664,908 ▲ 17% vs 2022 (€ 568,599) Unchanged	€ 764,336 Balance sheet total 2024: € 764,336 ▲ 15% vs 2023 (€ 664,908) Unchanged	€ 798,112 Balance sheet total 2025: € 798,112 ▲ 4% vs 2024 (€ 764,336) Unchanged	▲ 4%

Key figures of DR. VERCAUTEREN ROELAND, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. VERCAUTEREN ROELAND?

What happened at DR. VERCAUTEREN ROELAND in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 24, 2026 New annual accounts for financial year 2025: profit of € 253,854 (▲ 32% vs 2024). filed late Source: NBB ↗
Feb 10, 2011 New establishment in Antwerpen. KBO
Jan 17, 2011 Start of the company according to the CBE. KBO

In short

From € 115,235 profit in 2022 to € 253,854 profit in 2025.

Paid € 307,976 in corporate taxes since 2022.

Best year ever: 2025, with € 253,854 profit.

Paid out € 458,528 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. VERCAUTEREN ROELAND? We notify you, reason included.

Follow DR. VERCAUTEREN ROELAND

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

ROELAND VERCAUTEREN

DR. VERCAUTEREN ROELAND

POLYBE 12%

Behind DR. VERCAUTEREN ROELAND is ROELAND VERCAUTEREN. It owns 12% of POLYBE itself.

See the full network in the app

Directors

According to the 2025 annual accounts

ROELAND VERCAUTEREN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Floralaan 20

2640 Mortsel

2.196.678.529

Oosterveldlaan 24

2610 Antwerpen

Active since 10 February 2011

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0833.634.232
VAT number: BE 0833.634.232
Registered office: Floralaan 20, 2640 Mortsel
Names & denominations: DR. VERCAUTEREN ROELAND
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 January 2011
Peppol: Active · Active since 27 Mar 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗